Editor's Picks

There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.

MedImmune, Inc.

MedImmune, Inc.

  1. Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Micromet
    Freshnews.com logo Freshnews.com 5 days ago

    Micromet has collaborations with a number of leading pharmaceutical and biotechnology companies, including Amgen, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim, MedImmune, Merck Serono, Nycomed and Sanofi. This news release contains...

  2. BSRC CASE Studentship on Engineering a new Generation of Antibodies
    Nature.com logo Nature.com 1 week ago

    For background: L.Holm et al. J Biol Chem. 2009 284(47):32906-13, P. Dufner et al. Trends Biotechnol. 2006 24(11):523-9. Further information: Dr Mark Howarth Lab http://users.ox.ac.uk/~bioc0756/MyWebs/activesite/ MedImmune...

  3. AP Photo logo AP Photo 4 months ago
    COMMERCIAL IMAGE -- In this photo released by AP Images for MedImmune on Thursday, October 13, 2011, Soccer all-star Brandi Chastain visits Anderson United Community School in Minneapolis where she gave a once-in-a-lifetime soccer clinic as part of "When...

    COMMERCIAL IMAGE -- In this photo released by AP Images for MedImmune on Thursday, October 13, 2011, Soccer all-star Brandi Chastain visits Anderson United Community School in Minneapolis where she gave a once-in-a-lifetime soccer clinic as part of "When... View Photo »

  4. Working with MedImmune to explore new ways to target treatments is a natural progression of the basic scientific discoveries that our teams have made in the last decade
    SOURCE: Milan News 2 months ago
  5. MedImmune, LLC - Strategic SWOT Analysis Review
    Market Research Reports 2 weeks ago

    MedImmune, LLC Key Recent Developments May 13, 2011: MedImmune To Present Eight Abstracts On Projects Regarding Thoracic And Respiratory Issues At Annual ATS International Conference Feb 16, 2011: MedImmune And PDL BioPharma Resolve Patent Disputes Jan...

  6. AstraZeneca News: Drug Giant to Cut 7,300 Jobs After Profit Warning
    International Business Times logo International Business Times 2 weeks ago

    But following the poorly received purchase of MedImmune for $15.6 billion in 2007, the company has so far eschewed another large deal and Brennan said his focus remained on small acquisitions. He told reporters MedImmune was a different scale of deal...

  7. DELAWARE: AstraZeneca cuts profit forecast; to lay off 7,300 more
    The Salisbury Daily Times logo The Salisbury Daily Times 2 weeks ago

    Brennan repeated the companys strategy to acquire products or smaller companies to add products to the companys pipeline and said hes not looking for "transformational" deals. Any acquisition would be smaller than the $14.7 billion purchase of...

  8. New types of partnerships between academic biomedical powerhouses such as Michigan, and industry leaders such as MedImmune, are needed to accelerate the search for those options.
    SOURCE: Milan News 2 months ago
  9. evac0324
    YouTube Logo YouTube Videos 35 months ago
  10. World's Leading Pharmaceutical Executives All Converging in Zurich, Switzerland on February 21-22, 2012 for Breakthrough Event
    PR Newswire logo PR Newswire 2 weeks ago

    Conference participants will benefit from the impressive speaking faculty of more than 40 expert speakers from prestigious companies like Actelion, Amgen, Bausch + Lomb, Chiesi Farmaceutici, DSM, F. Hoffmann-La Roche, GlaxoSmithKline, Helsinn...

  11. Übernahme von Micromet Durch Amgen
    PR Newswire logo PR Newswire 3 weeks ago

    Micromet arbeitet mit einer Reihe von führenden pharmazeutischen und Biotechnologieunternehmen zusammen, darunter Amgen, Bayer Health Care Pharmaceuticals, Böhringer Ingelheim, MedImmune, Merck Serono, Nycomed und Sanofi. Blinatumomab ist ein...

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using Daylife platform, which helps you be more efficient and creative with content. It's designed for publishers, editors, and developers to build better content-based sites, services, and apps for clients and audiences. Learn More »

About MedImmune, Inc.

Wikipedia

MedImmune, LLC, headquartered in Gaithersburg, Maryland, became a wholly owned subsidiary of AstraZeneca in 2007. Since being acquired, MedImmune has remained a Maryland-based biotechnology development enterprise. It produces Synagis, a drug for the prevention of respiratory infections in infants, which accounted for $1.06 billion of its $1.2... Full Article

Related Photos

Related Topics

  1. AstraZeneca PLC AstraZeneca PLC
  2. University of Michigan University of Michigan
  3. NYSE NYSE
  4. ICO, Inc. ICO, Inc.
  5. Warburg Pincus

Timeline of Coverage

  1. Click to see all coverage from Jan 04, 2012
    0
    January 04, 2012
  2. Click to see all coverage from Jan 05, 2012
    0
    January 05, 2012
  3. Click to see all coverage from Jan 06, 2012
    0
    January 06, 2012
  4. Click to see all coverage from Jan 07, 2012
    0
    January 07, 2012
  5. Click to see all coverage from Jan 08, 2012
    0
    January 08, 2012
  6. Click to see all coverage from Jan 09, 2012
    0
    January 09, 2012
  7. Click to see all coverage from Jan 10, 2012
    0
    January 10, 2012
  8. Click to see all coverage from Jan 11, 2012
    0
    January 11, 2012
  9. Click to see all coverage from Jan 12, 2012
    0
    January 12, 2012
  10. Click to see all coverage from Jan 13, 2012
    0
    January 13, 2012
  11. Click to see all coverage from Jan 14, 2012
    0
    January 14, 2012
  12. Click to see all coverage from Jan 15, 2012
    0
    January 15, 2012
  13. Click to see all coverage from Jan 16, 2012
    0
    January 16, 2012
  14. Click to see all coverage from Jan 17, 2012
    0
    January 17, 2012
  15. Click to see all coverage from Jan 18, 2012
    0
    January 18, 2012
  16. Click to see all coverage from Jan 19, 2012
    0
    January 19, 2012
  17. Click to see all coverage from Jan 20, 2012
    2
    January 20, 2012
  18. Click to see all coverage from Jan 21, 2012
    0
    January 21, 2012
  19. Click to see all coverage from Jan 22, 2012
    0
    January 22, 2012
  20. Click to see all coverage from Jan 23, 2012
    0
    January 23, 2012
  21. Click to see all coverage from Jan 24, 2012
    0
    January 24, 2012
  22. Click to see all coverage from Jan 25, 2012
    0
    January 25, 2012
  23. Click to see all coverage from Jan 26, 2012
    0
    January 26, 2012
  24. Click to see all coverage from Jan 27, 2012
    0
    January 27, 2012
  25. Click to see all coverage from Jan 28, 2012
    0
    January 28, 2012
  26. Click to see all coverage from Jan 29, 2012
    0
    January 29, 2012
  27. Click to see all coverage from Jan 30, 2012
    0
    January 30, 2012
  28. Click to see all coverage from Jan 31, 2012
    0
    January 31, 2012
  29. Click to see all coverage from Feb 01, 2012
    0
    February 01, 2012
  30. Click to see all coverage from Feb 02, 2012
    0
    February 02, 2012
  31. Click to see all coverage from Feb 03, 2012
    0
    February 03, 2012
  32. Click to see all coverage from Feb 04, 2012
    0
    February 04, 2012
  33. Click to see all coverage from Feb 05, 2012
    0
    February 05, 2012
  34. Click to see all coverage from Feb 06, 2012
    1
    February 06, 2012
  35. Click to see all coverage from Feb 07, 2012
    0
    February 07, 2012
  36. Click to see all coverage from Feb 08, 2012
    0
    February 08, 2012
  37. Click to see all coverage from Feb 09, 2012
    0
    February 09, 2012
  38. Click to see all coverage from Feb 10, 2012
    1
    February 10, 2012
  39. Click to see all coverage from Feb 11, 2012
    0
    February 11, 2012
  40. Click to see all coverage from Feb 12, 2012
    0
    February 12, 2012
  41. Click to see all coverage from Feb 13, 2012
    0
    February 13, 2012
  42. Click to see all coverage from Feb 14, 2012
    0
    February 14, 2012
  43. Click to see all coverage from Feb 15, 2012
    0
    February 15, 2012
  44. Click to see all coverage from Feb 16, 2012
    0
    February 16, 2012
  45. Click to see all coverage from Feb 17, 2012
    0
    February 17, 2012
  46. Click to see all coverage from Feb 18, 2012
    0
    February 18, 2012
  47. Click to see all coverage from Feb 19, 2012
    0
    February 19, 2012
  48. Click to see all coverage from Feb 20, 2012
    0
    February 20, 2012

Related Videos

  1. Videosurf
    1. David Mott, Keynote Speaker, Mid-Atlantic Bio
      David Mott, Keynote Speaker, Mid-Atlantic Bio
    2. evac0324
      evac0324
    View All Videosurf Videos »

Related Quotes

  • Previous
  • Next
  • 1/5
  1. Working with MedImmune to explore new ways to target treatments is a natural progression of the basic scientific discoveries that our teams have made in the last decade
    SOURCE: Milan News 2 months ago
  2. New types of partnerships between academic biomedical powerhouses such as Michigan, and industry leaders such as MedImmune, are needed to accelerate the search for those options.
    SOURCE: Milan News 2 months ago
  3. We are thrilled to partner with MedImmune in a collaborative and creative way to bring new innovations to market
    SOURCE: Milan News 2 months ago
  4. We believe that in the current financial environment, there is a growing role for corporate venture capital funds such as MedImmune Ventures ... We look forward to expanding our investment activities globally and across therapy areas.
    SOURCE: Philadelphia Business Journal 2 months ago
  5. We continue to support MedImmune Ventures strategy that combines commitment to advance science and technology in the life science industry while generating financial returns expected of venture capital funds.
    SOURCE: World Pharma News 2 months ago
View All »